Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatment.

Among these 4 patients, 1 showed a trend toward exacerbation for up to 10 months after initiating cell administration ( Fig. 4H ).

also in 53,322 other papers

As a result, although the ALSFRS-R scores tended to improve 12 months post-treatment compared with 3 months before CL2020 administration, the difference did not reach statistical significance, likely due to the incident experienced by patient #2.

also in 111,027 other papers